Total buying$00 buys
MEDP
Medpace Holdings, Inc.
NasdaqConsumer DiscretionaryServices-Commercial Physical & Biological Research
Insider activity for last month from 09/19 to 10/19.
How these metrics are calculated
Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total selling$103M8 sells
Net open-market−$103MBuying minus selling
Active insiders5Distinct reporting owners
Insider activity report
Calendar-month buckets within the selected date range
Latest filing: Oct 14, 2026
Open-market transaction mix · 8 transactions in the selected period
Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.
View exact monthly counts and disclosed values
| Month | Buys | Sells | Awards (A) | Buy value | Sell value | Net P/S value |
|---|---|---|---|---|---|---|
| Sep 2026 | 0 | 8 | 0 | $0 | $103M | -$103M |
| Oct 2026 | 0 | 0 | 0 | $0 | $0 | $0 |
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (4)Sep 2026Oct 2026
Largest insider activity
By absolute net disclosed value · current transaction page- TJ-$103.7M
- BE+$833.6k
- MI—
- KO—
- CT—
MEDP transaction history
Newest filings · 20 transactions per pageLatest insider transactions
Form 4 filings from last month.Filing-only signals
Deterministic matches in the selected period
Filing detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period18transactionstxns
- M · Option exercise · dominant10 · 56%
- S · Open-market sells8 · 44%
Activity by reported role
A joint filing can contribute to multiple rolesChief executive officer8
PRES8
Director6
EV4
Reported Holdings After
Separated by insider, security, and ownership type
Troendle August J.Common Stock · Direct
338,225Sep 30, 2026
Burwig Susan ECommon Stock · Direct
70,984Oct 12, 2026
Burwig Susan EEmployee Stock Option (Right to Buy) · Direct
3,028Oct 12, 2026
Carley Brian TCommon Stock · Direct
27,861Sep 30, 2026
Carley Brian TRestricted Stock Unit · Direct
35Sep 30, 2026
Kraft Robert O.Common Stock · Direct
987Sep 30, 2026
Kraft Robert O.Restricted Stock Unit · Direct
32Sep 30, 2026
McCarthy Cornelius P. IIICommon Stock · Direct
12,303Sep 30, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells redSep 19 → Oct 19
LessMore
Medpace Holdings, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Medpace Holdings, Inc.?
BURWIG SUSAN E, McCarthy Cornelius P. III, Kraft Robert O., Carley Brian T, Troendle August J..
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Troendle August J. reported a sale on Sep 30, 2026 valued at $13.7M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $103,742,916.20. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.